REALM THERAPEUTICS
Realm Therapeutics is a biopharmaceutical company passionately committed to leveraging its proprietary technologies to protect and improve the health of adults and children. The Company's drug development focus, utilizing its immunomodulatory formulations, is targeted initially on developing small molecule therapies in inflammatory diseases with potential application in dermatology and ophthalmology, and the potential for broad applicability across a number of other diseases.
REALM THERAPEUTICS
Social Links:
Industry:
Biotechnology Pharmaceutical
Founded:
2006-01-01
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.realmtx.com
Total Employee:
101+
Status:
Active
Contact:
(484)321-2700
Total Funding:
26 M USD
Technology used in webpage:
SPF Nginx Amazon Mobile Optimized Drupal Amazon Ohio Region NameBright Drupal 8 ViaWest
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-08-05 | Labcaire Systems | Labcaire Systems acquired by Realm Therapeutics | 4.6 M USD |
Investors List
Biotechnology Value Fund
Biotechnology Value Fund investment in Post-IPO Equity - Realm Therapeutics
OrbiMed
OrbiMed investment in Post-IPO Equity - Realm Therapeutics
Polar Capital Holdings
Polar Capital Holdings investment in Post-IPO Equity - Realm Therapeutics
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Realm Therapeutics
Abingworth
Abingworth investment in Post-IPO Equity - Realm Therapeutics
Official Site Inspections
http://www.realmtx.com
- Host name: ec2-3-140-13-188.us-east-2.compute.amazonaws.com
- IP address: 3.140.13.188
- Location: Columbus United States
- Latitude: 39.9653
- Longitude: -83.0235
- Metro Code: 535
- Timezone: America/New_York
- Postal: 43215
More informations about "Realm Therapeutics"
Realm Therapeutics, Inc. | LinkedIn
Realm Therapeutics (AIM: RLM) is a clinical-stage biopharmaceutical company focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and …See details»
Realm Therapeutics - Crunchbase Company Profile
Realm Therapeutics is a biopharmaceutical company passionately committed to leveraging its proprietary technologies to protect and improve the health of …See details»
Realm Therapeutics - Craft
Jun 26, 2019 · Realm Therapeutics is a biopharmaceutical company that focuses on developing immunomodulatory therapies for the treatment of dermatology and ophthalmology diseases.See details»
Realm Therapeutics Company Profile 2024: Valuation, Investors ...
Information on acquisition, funding, investors, and executives for Realm Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Realm Therapeutics, Inc. Management Team | Org Chart
The Company has developed proprietary formulations of our novel technology for initial application in Atopic Dermatitis (PR022), Acne (PR023) and Allergic Conjunctivitis (PR013), as …See details»
Realm Therapeutics Announces 2018 Annual Report Available and …
MALVERN, Pa., April 10, 2019 /PRNewswire/ -- Realm Therapeutics plc (NASDAQ: RLM) today announces that its 2018 Annual Report is now available on the Company's website, …See details»
Realm Therapeutics Announces Result of General Meeting - PR …
Mar 15, 2019 · Shareholders can find information on how to convert their Ordinary Shares into ADSs on the Company's website: www.realmtx.com in the Investors section under Events & …See details»
Realm Therapeutics - Overview, News & Similar companies
May 16, 2019 · View Realm Therapeutics (www.realmtx.com) location in Greater London, United Kingdom , revenue, industry and description. Find related and similar companies as well as …See details»
Realm Therapeutics Announces Results of 2018 Annual General …
Jun 14, 2018 · Realm Therapeutics is a clinical-stage biopharmaceutical company developing novel therapeutics that target the interplay between innate and adaptive immunity. The …See details»
Realm Therapeutics Announces 2018 Annual Report Available
Apr 10, 2019 · Realm Therapeutics plc announces that its 2018 Annual Report is now available on the Company's website, www.realmtx.com, and will be posted to those shareholders who …See details»
Realm Therapeutics Announces Result of General Meeting
Mar 15, 2019 · Shareholders can find information on how to convert their Ordinary Shares into ADSs on the Company's website: www.realmtx.com in the Investors section under Events & …See details»
Realm Therapeutics to Present at the 2018 Wedbush PacGrow
Aug 8, 2018 · Realm Therapeutics is a clinical-stage biopharmaceutical company developing novel therapeutics that target the interplay between innate and adaptive immunity. The …See details»
Realm Therapeutics Strengthens its Patent Portfolio with Two New …
Feb 27, 2018 · Realm Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel therapeutics that target the intersection between innate and adaptive …See details»
Realm - Crunchbase Company Profile & Funding
Realm makes it easy to build modern reactive apps, realtime collaborative features, and offline-first experiences. View contacts for Realm to access new leads and connect with decision …See details»
Articles about Realm Therapeutics, Inc. - BioSpace
Feb 15, 2019 · Realm Therapeutics plc (AIM: RLM), a clinical stage biopharmaceutical company focused on developing novel therapeutics in immune-mediated diseases, today announces …See details»
Meta Developers - Oculus VR
Manage your organization. Create your organization. Add financial settings. Get financial reports. Verify your org. Manage multiple orgs. Manage test users. Business models and strategy. …See details»
Realm Therapeutics plc ("Realm Therapeutics", "Realm" or the …
MALVERN, Pa., Feb. 15, 2019 /PRNewswire/ -- Realm Therapeutics plc (NASDAQ: RLM / AIM: RLM), a biopharmaceutical company with a proprietary technology platform of stabilized high …See details»
Tech For Troops - Serving Those Who Served
Formed in 2014, we are a non-partisan, non-discriminatory Veteran services organization. We prioritize Veterans as they re-acclimate to civilian life. Individual Vets. We supply qualifying …See details»
Realm Therapeutics Announces Completion of Assets Disposal
MALVERN, Pa., March 29, 2019 /PRNewswire/ -- Realm Therapeutics plc (NASDAQ: RLM ) today announces the completion of its previously announced Assets Disposal representing …See details»